ArticleIn vivo (Athens, Greece)
Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimProstate cancer (PCa) is a leading malignancy in men worldwide. Despite its routine use, PSA testing lacks specificity and often results in unnecessary biopsies, especially in men with borderline PSA values. Urinary metabolomic profiling may offer a fully non-invasive approach to detect tumor-related metabolic alterations. Amino acids are of interest due to their roles in cancer metabolism, proliferation, and redox regulation. Building on our previous pilot study, we assessed whether urinary amino acid concentrations can differentiate PCa from benign cases, identify high-risk disease, and provide diagnostic information independent of prostate volume or prior prostate manipulation. PATIENTS AND
methodsFirst-morning urine samples without prior prostate manipulation were collected from 90 men: 60 with histologically confirmed PCa and 30 healthy controls. Total urinary amino acids were quantified using high-performance liquid chromatography with fluorescence detection and normalized to creatinine. The primary analysis compared amino acid concentrations between PCa and controls. Secondary analyses assessed associations with PSA, prostate volume, lymph-node status, surgical margins, postoperative PSA detectability, and preoperative risk category.
resultsSignificant alterations were observed in glutamate+glutamine (
conclusionUrinary amino acid profiling shows promise as a non-invasive adjunct to PSA testing. This cohort validates our prior pilot data. Specific amino acids may improve diagnostic specificity, particularly in men with borderline PSA. The approach without prior prostate manipulation, patient-friendly sampling enhances outpatient applicability. Larger multi-center validation is warranted to confirm diagnostic potential and assess integration with PSA testing to reduce unnecessary biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.